NCT06786455

Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 12 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy of subcutaneous injection of SHR-1905 in adolescent asthmatic subjects - an open-label, single-dose Phase II clinical study

Conditions

• Adolescent Asthma

Interventions

Type	Name	Description
DRUG	SHR-1905 Injection	SHR-1905 Injection,medium dose, administered by subcutaneous injection;

Timeline

• Start date: 2025-01-23
• Primary completion: 2025-12-03
• Completion: 2025-12-03
• First posted: 2025-01-22
• Last updated: 2025-12-18

Locations

1 site across 1 country: China